{"entity":{"type":"insider","cik":"0001543792","url":"/insider/0001543792","json_url":"/insider/0001543792.json","name":"Posard Matthew L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":8,"first":"2013-04-15","last":"2024-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Posard Matthew L.","source":"filing","n_filings":8,"first_seen":"2013-04-15","last_seen":"2024-08-14"}],"transactions":[{"id":3237289,"accession":"0001415889-24-021305","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-021305","line_url":"/filing/0001415889-24-021305#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9881.0,"shares_display":"9,881","price_per_share":57.7,"price_display":"57.70","price_state":"stated","total_value":570133.7,"total_display":"570,133.70","total_whole":"570,134","shares_owned_after":69874.0,"shares_owned_after_display":"69,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-14","scope":"insider"},{"id":3237283,"accession":"0001415889-24-021305","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-021305","line_url":"/filing/0001415889-24-021305#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":56.193,"price_display":"56.19","price_state":"stated","total_value":561930.0,"total_display":"561,930.00","total_whole":"561,930","shares_owned_after":79755.0,"shares_owned_after_display":"79,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-14","scope":"insider"},{"id":3237277,"accession":"0001415889-24-021305","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-021305","line_url":"/filing/0001415889-24-021305#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.723,"price_display":"55.72","price_state":"stated","total_value":557230.0,"total_display":"557,230.00","total_whole":"557,230","shares_owned_after":89755.0,"shares_owned_after_display":"89,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-14","scope":"insider"},{"id":2131874,"accession":"0001415889-24-016672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-016672","line_url":"/filing/0001415889-24-016672#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.619,"price_display":"50.62","price_state":"stated","total_value":506190.0,"total_display":"506,190.00","total_whole":"506,190","shares_owned_after":99755.0,"shares_owned_after_display":"99,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-13","scope":"insider"},{"id":2131868,"accession":"0001415889-24-016672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-016672","line_url":"/filing/0001415889-24-016672#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.011,"price_display":"50.01","price_state":"stated","total_value":500110.0,"total_display":"500,110.00","total_whole":"500,110","shares_owned_after":109755.0,"shares_owned_after_display":"109,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-13","scope":"insider"},{"id":6273312,"accession":"0001415889-22-012142","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-22-012142","line_url":"/filing/0001415889-22-012142#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":56.118,"price_display":"56.12","price_state":"stated","total_value":561180.0,"total_display":"561,180.00","total_whole":"561,180","shares_owned_after":105189.0,"shares_owned_after_display":"105,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-06","scope":"insider"},{"id":6273310,"accession":"0001415889-22-012142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-012142","line_url":"/filing/0001415889-22-012142#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.737,"price_display":"55.74","price_state":"stated","total_value":557370.0,"total_display":"557,370.00","total_whole":"557,370","shares_owned_after":115189.0,"shares_owned_after_display":"115,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-05","filed_date":"2022-12-06","scope":"insider"},{"id":6273307,"accession":"0001415889-22-012142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-012142","line_url":"/filing/0001415889-22-012142#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":58.8,"price_display":"58.80","price_state":"stated","total_value":588000.0,"total_display":"588,000.00","total_whole":"588,000","shares_owned_after":125189.0,"shares_owned_after_display":"125,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"},{"id":5124352,"accession":"0001808805-21-000026","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001808805-21-000026","line_url":"/filing/0001808805-21-000026","is_derivative":false,"issuer_cik":"0001543792","issuer_name":"Nautilus Biotechnology, Inc.","issuer_ticker":"NAUT","issuer_name_source":null,"issuer_url":"/issuer/0001543792","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":4.470166666666667,"price_display":"4.47","price_state":"stated","total_value":134105.0,"total_display":"134,105.00","total_whole":"134,105","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-01","scope":"insider","n_lines":3},{"id":5124349,"accession":"0001808805-21-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808805-21-000026","line_url":"/filing/0001808805-21-000026#line-1","is_derivative":false,"issuer_cik":"0001543792","issuer_name":"Nautilus Biotechnology, Inc.","issuer_ticker":"NAUT","issuer_name_source":null,"issuer_url":"/issuer/0001543792","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.57,"price_display":"4.57","price_state":"stated","total_value":91400.0,"total_display":"91,400.00","total_whole":"91,400","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-01","scope":"insider"},{"id":4259284,"accession":"0001209191-21-012515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-012515","line_url":"/filing/0001209191-21-012515#line-1","is_derivative":false,"issuer_cik":"0001543792","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001543792","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62500.0,"shares_display":"62,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":62500.0,"shares_owned_after_display":"62,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-19","scope":"insider"},{"id":4361631,"accession":"0001209191-21-003423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-003423","line_url":"/filing/0001209191-21-003423#line-1","is_derivative":false,"issuer_cik":"0001543792","issuer_name":"DermTech, Inc.","issuer_ticker":"DMTK","issuer_name_source":null,"issuer_url":"/issuer/0001543792","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33898.0,"shares_display":"33,898","price_per_share":29.5,"price_display":"29.50","price_state":"stated","total_value":999991.0,"total_display":"999,991.00","total_whole":"999,991","shares_owned_after":86863.0,"shares_owned_after_display":"86,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":5437541,"accession":"0001110803-13-000209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001110803-13-000209","line_url":"/filing/0001110803-13-000209#line-2","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA INC","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Officer (Sr VP & General Manager)","role_mark":"O","role_mark_label":"Officer (Sr VP & General Manager)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP & General Manager","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2836.0,"shares_display":"2,836","price_per_share":70.8,"price_display":"70.80","price_state":"stated","total_value":200788.8,"total_display":"200,788.80","total_whole":"200,789","shares_owned_after":30858.0,"shares_owned_after_display":"30,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-30","filed_date":"2013-05-30","scope":"insider"},{"id":4671631,"accession":"0001110803-13-000154","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001110803-13-000154","line_url":"/filing/0001110803-13-000154","is_derivative":false,"issuer_cik":"0001110803","issuer_name":"ILLUMINA INC","issuer_ticker":"ILMN","issuer_name_source":null,"issuer_url":"/issuer/0001110803","owner_cik":"0001543792","owner_name":"Posard Matthew L.","owner_display_name":"Posard Matthew L.","owner_url":"/insider/0001543792","role":"Officer (Sr VP & General Manager)","role_mark":"O","role_mark_label":"Officer (Sr VP & General Manager)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP & General Manager","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48232.0,"shares_display":"48,232","price_per_share":57.95,"price_display":"57.95","price_state":"stated","total_value":2795044.4,"total_display":"2,795,044.40","total_whole":"2,795,044","shares_owned_after":30858.0,"shares_owned_after_display":"30,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-11","filed_date":"2013-04-15","scope":"insider","n_lines":8}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001159036","name":"HALOZYME THERAPEUTICS, INC.","url":"/issuer/0001159036","role":"Director","n_filings":3,"first_seen":"2022-12-06","last_seen":"2024-08-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001808805","name":"Nautilus Biotechnology, Inc.","url":"/issuer/0001808805","role":"Director","n_filings":1,"first_seen":"2021-12-01","last_seen":"2021-12-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001584751","name":"Talis Biomedical Corp","url":"/issuer/0001584751","role":"Director","n_filings":1,"first_seen":"2021-02-19","last_seen":"2021-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001651944","name":"DermTech, Inc.","url":"/issuer/0001651944","role":"Director","n_filings":1,"first_seen":"2021-01-13","last_seen":"2021-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001110803","name":"ILLUMINA INC","url":"/issuer/0001110803","role":"Officer (Sr VP & General Manager)","n_filings":2,"first_seen":"2013-04-15","last_seen":"2013-05-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001543792","retrieved_at":"2026-08-24T22:20:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}